Why is JBS stock sliding today?

JBS stock slid 6.3% in after-hours trading after the company released third-quarter 2026 results that fell well short of Wall Street’s expectations across nearly every key profitability metric.

Net income attributable to JBS came in at $164 million, down 72% from the same period a year earlier, while adjusted EBITDA on an IFRS basis dropped 36% to $1.181 billion, missing the analyst consensus of roughly $1.32 billion. Reported earnings per share of $0.15 came in less than half the $0.32 consensus estimate, extending a pattern of earnings disappointments that had already seen EPS estimates revised down nearly 32% over the prior two months.

The results were weighed down by deterioration across multiple business units. Free cash flow turned negative at $167 million, driven by weaker earnings and elevated inventory builds tied to China’s 2027 quota cycle, while net leverage climbed to 3.54x from 2.39x a year ago — a level that unsettled investors already sensitive to the company’s debt load.

Adding to the pressure, JBS announced the $542 million acquisition of Flora, a Brazilian personal care and hygiene company, and the $11 million purchase of Canal Rural, an agribusiness media outlet — both from J&F Group, JBS’s own controlling shareholder — raising related-party governance concerns and share dilution worries given that the Flora deal will be settled primarily in JBS stock.

The broader U.S. equity market provided no cover for the stock-specific selloff, with the S&P 500 edging up just 0.1% and the Nasdaq gaining 0.2% on the day as oil prices eased and investors rotated back into growth names. JBS’s protein sector peers had already been navigating a challenging environment of falling global meat prices and compressed margins, and the Q3 print confirmed that those headwinds had hit JBS harder than anticipated. JPMorgan analyst Lucas Ferreira had already trimmed his price target on the stock from $18 to $17.50 in late October, citing near-term earnings and leverage headwinds.

Taken together, a severe earnings miss, a sharp deterioration in cash generation and returns, rising leverage, and the announcement of two related-party deals — all released simultaneously after the close — created a confluence of negative catalysts that sent JBS shares to $12.30 in after-hours trading, a level that sits closer to the stock’s 52-week low of $10.61 than its 52-week high of $18.65.